How Did Electronics and Pharma Sectors Capture 70% of PLI Funds in FY25?
Click to start listening
Synopsis
In a remarkable financial year, the electronics and pharmaceutical industries have collectively seized a staggering 70% of the government's PLI scheme funds, significantly impacting India's manufacturing landscape. Discover the pivotal role of these sectors in driving export growth and enhancing the nation's industrial prowess.
Key Takeaways
- Electronics and pharma sectors received 70% of PLI funds.
- Electronics exports grew by 32.46% in FY25.
- Pharmaceutical exports reached $30.5 billion.
- Computer hardware exports doubled in FY25.
- PLI scheme enhances India's manufacturing capabilities.
New Delhi, July 13 (NationPress) The electronics and pharmaceutical industries have emerged as the primary beneficiaries of the government’s production-linked incentive (PLI) scheme for the fiscal year 2024-25, capturing nearly 70 percent of the total funds allocated, based on official statistics.
Out of a total of Rs 10,114 crore disbursed under the scheme during this period, the electronics sector was allocated Rs 5,732 crore, while the pharma sector received Rs 2,328 crore, as indicated by the data.
Initiated in 2021 to enhance domestic manufacturing, the PLI scheme was originally designed for 14 key sectors.
Since its inception, it has significantly contributed to fortifying India’s industrial framework and promoting increased value-added exports.
The effectiveness of the scheme is evident in the remarkable growth of the electronics sector.
Thanks to a robust manufacturing drive, electronics have secured a position among India’s top three export categories.
The sector achieved an astonishing export growth of 32.46 percent in 2024-25, with exports climbing from $29.12 billion in 2023-24 to $38.58 billion in the preceding fiscal year.
This marks a significant increase from $15.7 billion in 2021-22 and $23.6 billion in 2022-23, according to government data.
A standout feature within the electronics category was computer hardware and peripherals, which experienced an impressive 101 percent increase, with exports doubling from $0.7 billion to $1.4 billion in FY25.
The top markets for Indian electronic products included the United Arab Emirates, United States, Netherlands, United Kingdom, and Italy.
The pharmaceutical sector also demonstrated resilience, with Indian medicines and drugs reaching over 200 countries.
In 2024-25, pharma exports surged by nearly 10 percent to reach $30.5 billion—a testament to the country’s growing global footprint in healthcare and pharmaceuticals.
The latest data underscores the expanding influence of the PLI scheme in propelling India's manufacturing and export goals, particularly in sectors where the nation is emerging as a global frontrunner.
Point of View
The data reflects a significant shift in India's manufacturing capabilities, with the PLI scheme acting as a catalyst for growth in the electronics and pharmaceutical sectors. This progress not only enhances our export potential but also establishes India as a competitive player on the global stage, aligning well with the nation's long-term industrial strategies.
NationPress
13/07/2025
Frequently Asked Questions
What is the PLI scheme?
The PLI scheme, launched in 2021, aims to boost domestic manufacturing across various sectors by providing financial incentives to companies.
Which sectors benefited the most from PLI in FY25?
The electronics and pharmaceutical sectors were the primary beneficiaries, receiving nearly 70% of the total funds disbursed.
How much did the electronics sector receive under PLI?
The electronics sector received Rs 5,732 crore in the financial year 2024-25.
What was the export growth rate for electronics in FY25?
The electronics sector recorded an impressive export growth rate of 32.46% in FY25.
How many countries does Indian pharma reach?
Indian pharmaceutical products are now exported to over 200 countries worldwide.
